CAM360 AMNIOGRAFT Trademark

Trademark Overview

On Tuesday, December 19, 2023, a trademark application was filed for CAM360 AMNIOGRAFT with the United States Patent and Trademark Office. The USPTO has given the CAM360 AMNIOGRAFT trademark a serial number of 98322150. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 8, 2025. This trademark is owned by BioTissue Holdings Inc.. The CAM360 AMNIOGRAFT trademark is filed in the Pharmaceutical Products category with the following description:

preserved human amniotic membrane tissue for surgical grafts
cam360 amniograft

General Information

Serial Number98322150
Word MarkCAM360 AMNIOGRAFT
Filing DateTuesday, December 19, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 13, 2025

Trademark Statements

Goods and Servicespreserved human amniotic membrane tissue for surgical grafts
NOT AVAILABLEAMNIOGRAFT

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 19, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioTissue Holdings Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiami, FL 33126
Party NameBioTissue Holdings Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiami, FL 33126

Trademark Events

Event DateEvent Description
Tuesday, December 19, 2023NEW APPLICATION ENTERED
Thursday, March 21, 2024TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, March 21, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, March 28, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 18, 2024ASSIGNED TO EXAMINER
Monday, July 22, 2024NON-FINAL ACTION E-MAILED
Thursday, October 17, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, January 21, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 22, 2024NON-FINAL ACTION WRITTEN
Monday, July 22, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 17, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, January 21, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 22, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 20, 2025FINAL REFUSAL E-MAILED
Thursday, February 20, 2025FINAL REFUSAL WRITTEN
Thursday, February 20, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, March 20, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, March 20, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 15, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 20, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 8, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 21, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, May 13, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 7, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 13, 2025PUBLISHED FOR OPPOSITION

Related Keywords

amniograft surgical grafts tissue membrane human amniotic preserved